Platelets and atherosclerosis.
D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001161:Arteriosclerosis / Q000097:blood* / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D001792:Blood Platelets / Q000166:cytology / Q000502:physiology*; D001808:Blood Vessels / Q000378:metabolism; D004041:Dietary Fats / Q000494:pharmacology; D015118:Eicosapentaenoic Acid; D011464:Epoprostenol / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008054:Lipid Peroxides / Q000378:metabolism; D008934:Mitogens / Q000097:blood; D010972:Platelet Activating Factor / Q000502:physiology; D010974:Platelet Aggregation / Q000187:drug effects; D013931:Thromboxanes / Q000378:metabolism
D004041:Dietary Fats; D005231:Fatty Acids, Unsaturated; D008054:Lipid Peroxides; D008934:Mitogens; D010972:Platelet Activating Factor; D013931:Thromboxanes; D015118:Eicosapentaenoic Acid; D011464:Epoprostenol; D015126:8,11,14-Eicosatrienoic Acid